RLYB
Price
$0.88
Change
-$0.01 (-1.12%)
Updated
Jan 17 closing price
Capitalization
36.31M
59 days until earnings call
VERU
Price
$0.98
Change
+$0.14 (+16.67%)
Updated
Jan 17 closing price
Capitalization
142.78M
18 days until earnings call
Ad is loading...

RLYB vs VERU

Header iconRLYB vs VERU Comparison
Open Charts RLYB vs VERUBanner chart's image
Rallybio
Price$0.88
Change-$0.01 (-1.12%)
Volume$116.86K
Capitalization36.31M
Veru
Price$0.98
Change+$0.14 (+16.67%)
Volume$4.91M
Capitalization142.78M
RLYB vs VERU Comparison Chart
Loading...
RLYB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VERU
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
RLYB vs. VERU commentary
Jan 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RLYB is a Hold and VERU is a Hold.

Ad is loading...
COMPARISON
Comparison
Jan 19, 2025
Stock price -- (RLYB: $0.88 vs. VERU: $0.98)
Brand notoriety: RLYB and VERU are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: RLYB: 128% vs. VERU: 314%
Market capitalization -- RLYB: $36.31M vs. VERU: $142.78M
RLYB [@Biotechnology] is valued at $36.31M. VERU’s [@Biotechnology] market capitalization is $142.78M. The market cap for tickers in the [@Biotechnology] industry ranges from $368.92B to $0. The average market capitalization across the [@Biotechnology] industry is $2.37B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

RLYB’s FA Score shows that 1 FA rating(s) are green whileVERU’s FA Score has 0 green FA rating(s).

  • RLYB’s FA Score: 1 green, 4 red.
  • VERU’s FA Score: 0 green, 5 red.
According to our system of comparison, both RLYB and VERU are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

RLYB’s TA Score shows that 4 TA indicator(s) are bullish while VERU’s TA Score has 6 bullish TA indicator(s).

  • RLYB’s TA Score: 4 bullish, 4 bearish.
  • VERU’s TA Score: 6 bullish, 1 bearish.
According to our system of comparison, VERU is a better buy in the short-term than RLYB.

Price Growth

RLYB (@Biotechnology) experienced а -6.89% price change this week, while VERU (@Biotechnology) price change was +24.76% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.44%. For the same industry, the average monthly price growth was +2.66%, and the average quarterly price growth was -1.92%.

Reported Earning Dates

RLYB is expected to report earnings on May 13, 2025.

VERU is expected to report earnings on May 07, 2025.

Industries' Descriptions

@Biotechnology (-1.44% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VERU($143M) has a higher market cap than RLYB($36.3M). VERU YTD gains are higher at: 49.946 vs. RLYB (-8.833). VERU has higher annual earnings (EBITDA): -36.2M vs. RLYB (-69.86M). RLYB has more cash in the bank: 75.1M vs. VERU (24.9M). RLYB has less debt than VERU: RLYB (230K) vs VERU (13.9M). VERU has higher revenues than RLYB: VERU (16.9M) vs RLYB (598K).
RLYBVERURLYB / VERU
Capitalization36.3M143M25%
EBITDA-69.86M-36.2M193%
Gain YTD-8.83349.946-18%
P/E RatioN/AN/A-
Revenue598K16.9M4%
Total Cash75.1M24.9M302%
Total Debt230K13.9M2%
FUNDAMENTALS RATINGS
VERU: Fundamental Ratings
VERU
OUTLOOK RATING
1..100
26
VALUATION
overvalued / fair valued / undervalued
1..100
100
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
40
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
RLYBVERU
RSI
ODDS (%)
Bullish Trend 11 days ago
90%
N/A
Stochastic
ODDS (%)
Bearish Trend 11 days ago
90%
Bullish Trend 11 days ago
78%
Momentum
ODDS (%)
Bullish Trend 11 days ago
83%
Bullish Trend 11 days ago
81%
MACD
ODDS (%)
Bullish Trend 11 days ago
80%
Bullish Trend 11 days ago
89%
TrendWeek
ODDS (%)
Bullish Trend 11 days ago
87%
Bullish Trend 11 days ago
82%
TrendMonth
ODDS (%)
Bearish Trend 11 days ago
87%
Bullish Trend 11 days ago
78%
Advances
ODDS (%)
Bullish Trend 12 days ago
87%
Bullish Trend 13 days ago
82%
Declines
ODDS (%)
Bearish Trend 26 days ago
86%
Bearish Trend 11 days ago
90%
BollingerBands
ODDS (%)
N/A
Bullish Trend 11 days ago
89%
Aroon
ODDS (%)
N/A
Bullish Trend 11 days ago
78%
View a ticker or compare two or three
Ad is loading...
RLYB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VERU
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AOSL41.603.29
+8.59%
Alpha and Omega Semiconductor Limited
WHF9.990.12
+1.22%
WhiteHorse Finance
IT515.703.64
+0.71%
Gartner
OGN15.74-0.44
-2.72%
Organon & Co
HOLO1.70-0.12
-6.59%
MicroCloud Hologram Inc

RLYB and

Correlation & Price change

A.I.dvisor indicates that over the last year, RLYB has been loosely correlated with PXXLF. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if RLYB jumps, then PXXLF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RLYB
1D Price
Change %
RLYB100%
-1.65%
PXXLF - RLYB
44%
Loosely correlated
N/A
CLYM - RLYB
41%
Loosely correlated
-2.99%
ALT - RLYB
36%
Loosely correlated
+2.24%
SEOVF - RLYB
34%
Loosely correlated
-3.59%
VERU - RLYB
34%
Loosely correlated
+15.61%
More

VERU and

Correlation & Price change

A.I.dvisor indicates that over the last year, VERU has been loosely correlated with PXXLF. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if VERU jumps, then PXXLF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VERU
1D Price
Change %
VERU100%
+15.61%
PXXLF - VERU
37%
Loosely correlated
N/A
PRAX - VERU
35%
Loosely correlated
+0.41%
RLYB - VERU
35%
Loosely correlated
-1.65%
CLYM - VERU
34%
Loosely correlated
-2.99%
QLGN - VERU
34%
Loosely correlated
+1.75%
More